Kanghong Pharmaceutical (002773): DME indications approved for Compaqap volume increase

Kanghong Pharmaceutical (002773): DME indications approved for Compaqap volume increase Compaq’s DME indications approved, the base of potential drug users significantly increased. Company announcement. A wholly-owned subsidiary, Kang Hong Biological, recently received the Compaq’s Ophthalmic Injection Supplement for Indications issued by the State Drug Administration.”Macular edema (DME)”. At present, Compaqap